News from ani pharmaceuticals, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( NASDAQ-NMS:ANIP,NASDAQ-NMS:BPAX)

Feb 01, 2016, 08:00 ET

ANI Pharmaceuticals Acquires Exclusive Rights to Distribute Three Generic Drug Products from H2-Pharma for $10 Million

 ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP) today announced that it has acquired the exclusive rights to distribute 1% and 2.5%...

Jan 05, 2016, 08:00 ET

ANI Pharmaceuticals Closes Transaction to Acquire Two NDAs from Merck for $75 Million

ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP) today announced that it has completed the acquisition of the NDAs for purified corticotropin gel...

Dec 29, 2015, 08:00 ET

ANI Pharmaceuticals Announces Launch of Flecainide Tablets

 ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP) today announced the commercial launch of Flecainide Acetate 50mg, 100mg, and 150mg tablets....

Dec 23, 2015, 08:00 ET

ANI Pharmaceuticals Announces Launch of Nimodipine 30mg Capsules

 ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP) today announced the commercial launch of Nimodipine 30mg Capsules, a product developed by...

Dec 17, 2015, 08:00 ET

ANI Pharmaceuticals Announces FDA Approval of Polyethylene Glycol 3350 Powder for Oral Solution, 17mg/Scoopful

ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) of...

Dec 08, 2015, 08:00 ET

ANI Pharmaceuticals Presents At Oppenheimer 26th Annual Healthcare Conference

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) will present today at the Oppenheimer & Co. 26th Annual Healthcare Conference at the Westin Grand...

Nov 03, 2015, 08:00 ET

ANI Pharmaceuticals Reports Third Quarter and Year-To-Date 2015 Results and Highlights

ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP) today reported financial results for the three and nine months ended September 30, 2015 and...

Nov 02, 2015, 08:00 ET

ANI Pharmaceuticals Announces Launch of Vancomycin Capsules

ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP) today announced the launch of Vancomycin HCl 125mg and 250mg capsules indicated for treatment of...

Oct 27, 2015, 08:00 ET

ANI Pharmaceuticals Schedules Conference Call for Third Quarter and Year-to-Date 2015 Financial Results

 ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) announced today that the Company plans to release its third quarter and year-to-date 2015 financial...

Oct 16, 2015, 08:00 ET

ANI Pharmaceuticals Announces Launch of Oxycodone Hydrochloride Oral Solution

ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP) today announced the launch of Oxycodone Hydrochloride Oral Solution 5mg/5mL indicated for...

Oct 13, 2015, 08:00 ET

ANI Pharmaceuticals Appoints Peter A. Lankau to Its Board of Directors

 ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP) announced today the appointment of Peter A. Lankau to the Company's Board of Directors to...

Oct 05, 2015, 08:00 ET

ANI Pharmaceuticals Announces Board Authorization of Stock Repurchase Program

ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP)  announced today that its Board of Directors has authorized a stock repurchase program under...

Sep 21, 2015, 08:00 ET

ANI Pharmaceuticals to Acquire Two NDAs from Merck for $75 Million

 ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP) today announced that it has agreed to acquire the NDAs for purified corticotropin gel and...

Aug 12, 2015, 08:00 ET

ANI Pharmaceuticals and IDT Australia Enter Partnership to Commercialize US Generic Drug Products

 ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP) today announced that it has completed an agreement with IDT Australia, Ltd. ("IDT") to...

Aug 04, 2015, 08:00 ET

ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights

ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP) today reported financial results for the three and six months ended June 30, 2015 and updated its...

Jul 28, 2015, 08:00 ET

ANI Pharmaceuticals Schedules Conference Call for Second Quarter and Year-to-Date 2015 Financial Results

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) announced today that the Company plans to release its second quarter and year-to-date 2015 financial...

Jul 27, 2015, 08:00 ET

ANI Pharmaceuticals and Sofgen Announce FDA Approval of Nimodipine 30mg Capsules

 ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP) today announced that its ANDA collaboration partner Sofgen has received approval from the...

Jul 13, 2015, 08:00 ET

ANI Pharmaceuticals Acquires 22 Generic Drug Products from Teva Pharmaceuticals for $25 million

 ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP) today announced that it has acquired 22 previously marketed generic drug products from Teva...

Jun 02, 2015, 09:36 ET

ANI Pharmaceuticals Announces FDA Approval of Oxycodone Hydrochloride Oral Solution 5mg/5mL

ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP) today announced that it has received approval from the U.S. Food and Drug Administration (FDA)...

May 15, 2015, 08:00 ET

ANI Pharmaceuticals Presents at the UBS Global Healthcare Conference

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) will present on May 20, 2015 at the UBS Global Healthcare Conference at the Sheraton New York Times Square...